Index S&P 500
P/E 16.92
EPS (ttm) 5.49
Insider Own 23.34%
Shs Outstand 1.63B
Perf Week 2.39%
Market Cap 151.03B
Forward P/E 12.34
EPS next Y 7.52
Insider Trans -0.11%
Shs Float 1.25B
Perf Month -0.72%
Income 8.96B
PEG 2.11
EPS next Q 1.67
Inst Own 62.54%
Short Float 1.28%
Perf Quarter 5.81%
Sales 99.76B
P/S 1.51
EPS this Y 31.54%
Inst Trans -1.02%
Short Ratio 1.91
Perf Half Y 30.01%
Book/sh 55.50
P/B 1.67
EPS next Y 10.41%
ROA 0.76%
Short Interest 15.93M
Perf Year 4.96%
Cash/sh -
P/C -
EPS next 5Y 8.00%
ROE 9.12%
52W Range 69.42 - 95.57
Perf YTD -0.45%
Dividend Est. 3.51 (3.78%)
P/FCF 16.54
EPS past 5Y 1.84%
ROI 2.55%
52W High -2.87%
Beta 1.39
Dividend TTM 3.33 (3.58%)
Quick Ratio -
Sales past 5Y 15.18%
Gross Margin -
52W Low 33.72%
ATR (14) 2.05
Dividend Ex-Date Apr 29, 2024
Current Ratio 1.37
EPS Y/Y TTM -5.92%
Oper. Margin 12.42%
RSI (14) 56.75
Volatility 1.70% 2.21%
Employees 80000
Debt/Eq 3.63
Sales Y/Y TTM 34.52%
Profit Margin 8.98%
Recom 2.36
Target Price 98.42
Option/Short Yes / Yes
LT Debt/Eq 2.54
EPS Q/Q 18.45%
Payout 62.71%
Rel Volume 0.55
Prev Close 92.56
Sales Surprise 5.11%
EPS Surprise 20.83%
Sales Q/Q 13.33%
Earnings Apr 16 BMO
Avg Volume 8.35M
Price 92.83
SMA20 1.48%
SMA50 3.92%
SMA200 8.51%
Trades
Volume 4,596,187
Change 0.29%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-17-24 Downgrade
Keefe Bruyette
Outperform → Mkt Perform
$102 → $91
Jan-17-24 Downgrade
JP Morgan
Overweight → Neutral
$94 → $87
Jan-09-24 Downgrade
HSBC Securities
Buy → Hold
$96
Nov-28-23 Downgrade
Societe Generale
Buy → Hold
Nov-20-23 Downgrade
Exane BNP Paribas
Outperform → Neutral
$85
Oct-23-23 Downgrade
Odeon
Buy → Hold
$79.15
Oct-20-23 Upgrade
Wolfe Research
Underperform → Peer Perform
Oct-11-23 Downgrade
UBS
Buy → Neutral
$110 → $84
Sep-07-23 Initiated
HSBC Securities
Buy
$99
Jul-12-23 Upgrade
Odeon
Hold → Buy
$94
Jan-18-23 Downgrade
Citigroup
Buy → Neutral
$100
Jan-10-23 Upgrade
Odeon
Sell → Hold
$88.75
Jan-04-23 Downgrade
Wolfe Research
Outperform → Underperform
$92
Oct-05-22 Downgrade
Atlantic Equities
Overweight → Neutral
$95 → $85
Sep-06-22 Downgrade
Odeon
Hold → Sell
May-03-22 Upgrade
Oppenheimer
Perform → Outperform
$111
Jan-28-22 Downgrade
Odeon
Buy → Hold
Dec-03-21 Upgrade
Citigroup
Neutral → Buy
$105 → $115
Oct-15-21 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$97
Oct-04-21 Reiterated
Jefferies
Buy
$108 → $119
Show Previous Ratings
Today 12:10PM
10:57AM
Apr-27-24 05:59PM
Apr-26-24 05:13PM
(The Wall Street Journal)
02:06PM
12:10PM
Loading…
12:10PM
09:33AM
09:13AM
09:08AM
09:01AM
05:00AM
04:31AM
Apr-25-24 06:20PM
02:29PM
02:24PM
02:11PM
Loading…
02:11PM
01:58PM
01:54PM
01:35PM
03:03AM
Apr-24-24 09:34PM
09:01PM
08:44PM
05:57PM
(Retail Banker International)
01:48PM
12:19PM
12:19PM
11:36AM
11:33AM
11:32AM
11:17AM
Loading…
11:17AM
11:15AM
10:52AM
10:50AM
10:43AM
10:40AM
10:38AM
10:35AM
10:00AM
09:19AM
08:28AM
04:01AM
Apr-23-24 09:00PM
01:21PM
10:00AM
08:18AM
08:17AM
08:10AM
Apr-22-24 05:47PM
05:03PM
03:33PM
03:09PM
01:33PM
12:11PM
10:07AM
08:00AM
04:39AM
Apr-19-24 09:00PM
03:19PM
12:07PM
11:59AM
11:49AM
11:47AM
10:55AM
06:56AM
Apr-18-24 04:05PM
02:30PM
Apr-17-24 05:08PM
04:33PM
03:13PM
09:56AM
08:50AM
08:11AM
07:42AM
07:41AM
04:12AM
04:00AM
02:40AM
01:46AM
Apr-16-24 10:58PM
10:41PM
10:31PM
04:56PM
04:24PM
(The Wall Street Journal)
01:45PM
(The Wall Street Journal)
12:30PM
12:19PM
12:05PM
12:00PM
(The Wall Street Journal)
11:52AM
11:52AM
11:06AM
11:02AM
11:02AM
10:53AM
(The Wall Street Journal)
10:48AM
10:24AM
(The Wall Street Journal)
10:23AM
10:08AM
10:04AM
(The Wall Street Journal)
Provides diversified financial services including brokerage, investment management and venture capital services
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
GORMAN JAMES P Executive Chairman Apr 18 '24 Sale 90.21 100,000 9,020,530 414,870 Apr 19 04:06 PM Smith Charles Aubrey III Chief Risk Officer Apr 17 '24 Sale 90.09 11,200 1,009,019 126,190 Apr 19 04:05 PM GORMAN JAMES P Executive Chairman Feb 12 '24 Sale 87.30 100,000 8,730,220 350,000 Feb 14 04:19 PM SAPERSTEIN ANDREW M Co-President Feb 12 '24 Sale 87.19 26,655 2,324,092 286,835 Feb 14 04:19 PM GROSSMAN ERIC F Chief Legal/Admin Officer Jan 31 '24 Sale 88.55 26,562 2,352,001 234,627 Feb 01 04:20 PM GROSSMAN ERIC F Chief Legal/Admin Officer Jan 30 '24 Sale 87.81 26,563 2,332,595 261,189 Feb 01 04:20 PM SAPERSTEIN ANDREW M Co-President Jan 30 '24 Sale 87.92 10,000 879,170 313,490 Feb 01 04:22 PM AKRAM RAJA Deputy Chief Financial Officer Jan 30 '24 Sale 87.41 4,500 393,346 93,134 Feb 01 04:21 PM GORMAN JAMES P Executive Chairman Jan 26 '24 Sale 87.93 50,000 4,396,400 379,701 Jan 26 04:36 PM GORMAN JAMES P Executive Chairman Jan 25 '24 Sale 87.93 50,000 4,396,435 400,000 Jan 25 04:03 PM SAPERSTEIN ANDREW M Co-President Jan 19 '24 Sale 84.13 10,000 841,344 323,490 Jan 19 04:15 PM AKRAM RAJA Deputy Chief Financial Officer Jan 18 '24 Sale 83.56 7,000 584,928 97,634 Jan 19 04:22 PM MORGAN STANLEY 10% Owner Oct 05 '23 Sale 50000.00 135 6,750,000 0 Oct 10 08:22 PM GORMAN JAMES P Chairman and CEO Jul 24 '23 Sale 95.19 125,000 11,898,812 1,011,345 Jul 26 04:11 PM PICK EDWARD N Co-President/Head of IS Jul 24 '23 Sale 94.33 100,000 9,433,050 604,845 Jul 26 04:14 PM SIMKOWITZ DANIEL A Head of Investment Management Jul 20 '23 Sale 93.78 37,608 3,526,852 319,040 Jul 21 04:18 PM GORMAN JAMES P Chairman and CEO Jul 19 '23 Sale 92.35 125,000 11,543,286 1,136,345 Jul 21 04:13 PM SAPERSTEIN ANDREW M Co-President/Head of WM Jul 19 '23 Sale 93.09 39,254 3,654,280 193,708 Jul 21 04:16 PM AKRAM RAJA Deputy Chief Financial Officer Jul 19 '23 Sale 92.00 13,500 1,242,000 82,984 Jul 21 04:11 PM Smith Charles Aubrey III Chief Risk Officer Jul 19 '23 Sale 92.41 5,600 517,520 136,513 Jul 21 04:20 PM MORGAN STANLEY 10% Owner Jun 09 '23 Sale 9.45 1,049,889 9,921,451 8,456,881 Jun 13 04:04 PM AKRAM RAJA Deputy Chief Financial Officer May 15 '23 Sale 82.95 7,320 607,198 96,484 May 17 04:08 PM GLOCER THOMAS H Director May 03 '23 Sale 87.11 4,535 395,021 98,110 May 05 04:16 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite